13F filer · CIK 93751 ↗
State Street
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$1.77T
+4.1% on the quarter before
Positions
4,786
120 new · 191 sold out
Top 10
20.9%
of the value
Est. gain
+$85.50B
on stocks held all quarter
Est. return
+5.2%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from State Street's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 33% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$7.10BNew · 0.0% → 0.4%+19,984,243 shares
- GE HealthCare~$1.43BNew · 0.0% → 0.1%+17,420,218 shares
- General Electric Co~$684.8MAdded · 0.2% → 0.3%+7,157,356 shares
- Visa Inc.~$579.9MAdded · 0.9% → 0.9%+2,572,159 shares
- Paccar Inc~$513.9MAdded · 0.1% → 0.1%+7,020,923 shares
- Broadcom~$509.9MAdded · 0.5% → 0.6%+794,832 shares
- Mastercard~$473.7MAdded · 0.7% → 0.7%+1,303,477 shares
- Insulet Corp~$440.4MAdded · 0.0% → 0.1%+1,380,774 shares
- SPDR Ser Tr~$361.3MAdded · 0.0% → 0.1%+11,698,737 shares
- Avista Corp~$357.0MAdded · 0.0% → 0.0%+8,410,300 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$6.40BSold out · 0.4% → 0.0%−19,611,463 shares
- Apple~$1.74BCut · 4.5% → 5.4%−10,575,631 shares
- Nvidia~$1.71BCut · 0.8% → 1.4%−6,161,931 shares
- Berkshire Hathaway Inc Del~$1.22BCut · 1.3% → 1.2%−3,942,994 shares
- Exxon Mobil Corp~$774.5MCut · 1.4% → 1.3%−7,063,058 shares
- Jpmorgan Chase & Co~$766.1MCut · 1.0% → 0.9%−5,878,759 shares
- Microsoft~$711.5MCut · 4.2% → 4.8%−2,467,798 shares
- Svb Financial Group~$709.5MSold out · 0.0% → 0.0%−3,082,695 shares
- South Jersey Inds Inc~$521.5MSold out · 0.0% → 0.0%−14,677,719 shares
- Union Pac Corp~$471.8MCut · 0.3% → 0.3%−2,344,191 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −1.8% · price +26.9% | 5.4% | $95.03B | +$20.15B | ||||||||
| MicrosoftCOM · shares −0.8% · price +20.2% | 4.8% | $84.21B | +$14.16B | ||||||||
| AmazonCOM · shares −1.3% · price +23.0% | 1.9% | $34.28B | +$6.40B | ||||||||
| NvidiaCOM · shares −6.3% · price +90.1% | 1.4% | $25.43B | +$12.05B | ||||||||
| Exxon Mobil CorpCOM · shares −3.2% · price −0.6% | 1.3% | $23.71B | −$138.4M | ||||||||
| AlphabetCAP STK CL A · shares −0.03% · price +17.6% | 1.3% | $22.50B | +$3.36B | ||||||||
| Johnson & JohnsonCOM · shares −1.3% · price −12.3% | 1.2% | $21.74B | −$3.04B | ||||||||
| Unitedhealth Group IncCOM · shares −1.4% · price −10.9% | 1.2% | $21.53B | −$2.62B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −5.5% · price −0.0% | 1.2% | $21.00B | −$8.9M | ||||||||
| TeslaCOM · shares +0.7% · price +68.4% | 1.2% | $20.68B | +$8.34B | ||||||||
| Chevron Corp NewCOM · shares −1.5% · price −9.1% | 1.2% | $20.53B | −$2.05B | ||||||||
| AlphabetCAP STK CL C · shares −1.4% · price +17.2% | 1.1% | $19.97B | +$2.93B | ||||||||
| MetaCL A · shares −1.5% · price +76.1% | 1.0% | $18.44B | +$7.97B | ||||||||
| Lockheed Martin CorpCOM · shares +0.5% · price −2.8% | 1.0% | $17.95B | −$520.1M | ||||||||
| Visa Inc.COM CL A · shares +3.7% · price +8.5% | 0.93% | $16.44B | +$1.24B | ||||||||
| Jpmorgan Chase & CoCOM · shares −4.5% · price −2.8% | 0.91% | $16.14B | −$469.5M | ||||||||
| Procter And Gamble CoCOM · shares −3.0% · price −1.9% | 0.86% | $15.21B | −$293.6M | ||||||||
| Home Depot IncCOM · shares −0.3% · price −6.6% | 0.76% | $13.44B | −$944.9M | ||||||||
| MastercardCL A · shares +3.9% · price +4.5% | 0.71% | $12.63B | +$524.6M | ||||||||
| Merck & Co IncCOM · shares −1.3% · price −4.1% | 0.70% | $12.47B | −$529.8M | ||||||||
| Abbvie IncCOM · shares −1.3% · price −1.4% | 0.69% | $12.28B | −$172.6M | ||||||||
| Raytheon Technologies CorpCOM · shares −0.9% · price −3.0% | 0.69% | $12.21B | −$372.9M | ||||||||
| Pfizer IncCOM · shares −0.8% · price −20.4% | 0.65% | $11.50B | −$2.94B | ||||||||
| Eli LillyCOM · shares −1.4% · price −6.1% | 0.64% | $11.41B | −$745.2M | ||||||||
| Pepsico IncCOM · shares −1.8% · price +0.3% | 0.60% | $10.68B | +$30.5M | ||||||||
| Total · 4,786 positions | 100% | $1.77T | +$85.50B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 4,465 stocks held throughout, up $85.50B (+5.2%).
- Apple+$20.15B+27%
- Microsoft+$14.16B+20%
- Nvidia+$12.05B+90%
- Tesla+$8.34B+68%
- Meta+$7.97B+76%
- Schwab Charles Corp−$1.85B−37%
- Chevron Corp New−$2.05B−9%
- Unitedhealth Group Inc−$2.62B−11%
- Pfizer Inc−$2.94B−20%
- Johnson & Johnson−$3.04B−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Sep 22, 2026 (amended) | $3.38T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $2.90T−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $2.98T+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.88T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.67T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $2.43T−4% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $2.53T+3% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.46T+7% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.29T+2% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.24T+9% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $2.06T+14% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $1.80T−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.90T+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $1.77T+4% | SEC ↗ |
| Q4 2022 | May 15, 2023 (amended) | $1.70T+8% | SEC ↗ |
| Q3 2022 | Nov 15, 2022 | $1.58T−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.67T−17% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.02T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.11T+11% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $1.89T−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $1.90T+9% | SEC ↗ |
| Q1 2021 | Jul 9, 2021 (amended) | $1.74T+7% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $1.63T+12% | SEC ↗ |
| Q3 2020 | Nov 10, 2020 | $1.46T+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $1.38T+20% | SEC ↗ |
| Q1 2020 | Jun 19, 2020 (amended) | $1.14T−22% | SEC ↗ |
| Q4 2019 | Feb 6, 2020 | $1.46T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 (amended) | $1.34T+0% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $1.34T+5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $1.28T+17% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $1.10T−16% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $1.30T+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $1.20T+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.18T−5% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.24T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.16T+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.13T+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.12T+5% | SEC ↗ |
| Q4 2016 | Feb 9, 2017 | $1.06T+7% | SEC ↗ |
| Q3 2016 | Jan 13, 2017 (amended) | $992.21B+7% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $930.88B+1% | SEC ↗ |
| Q1 2016 | May 20, 2016 (amended) | $924.92B | SEC ↗ |